Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. HELP
HELP logo

HELP

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

HELP News

Tilray Expands Medical Cannabis Platform with HelloMD Acquisition

1d agoYahoo Finance

Rapid Growth in Major Depressive Disorder Treatment Market

Jun 30 2026Newsfilter

Cybin Reports FY Net Loss of $148 Million, Up from $81.6 Million Last Year

Jun 29 2026seekingalpha

Helus Pharma's HLP003 Phase 3 Trial Enrollment Surpasses 86%

Jun 26 2026PRnewswire

Helus Pharma's HLP003 Phase 3 Trial Surpasses 86% Enrollment

Jun 26 2026Newsfilter

Bio-Techne Soars Over 20% on Merck Acquisition News

Jun 26 2026NASDAQ.COM

Helus Pharma Closes $50 Million Underwritten Offering

Jun 25 2026Newsfilter

Helus Pharma Reports Clinical Progress and Financing Plans

Jun 24 2026NASDAQ.COM

Helus Pharma Prices $50 Million Underwritten Offering

Jun 24 2026NASDAQ.COM

Helus Pharma Prices Public Offering at $4.85 per Share

Jun 24 2026seekingalpha

Helus Pharma Prices $50 Million Underwritten Offering

Jun 24 2026Newsfilter

Helus Pharma to Participate in Neuro Perspectives Conference

Jun 11 2026Newsfilter

Helus Pharma CEO to Participate in Healthcare Conference

Jun 01 2026Newsfilter

BetterLife Appoints Doug Drysdale as Executive Chairman

May 13 2026Yahoo Finance

Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health

Apr 30 2026Newsfilter

Helus Pharma CEO to Speak at Health Innovation Forum

Apr 30 2026Newsfilter